SYRA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Syra Health Corp (SYRA).


$3.70M Market Cap.

As of 03/11/2025 5:00 PM ET (MRY) • Disclaimer

SYRA Market Cap. (MRY)


SYRA Shares Outstanding (MRY)


SYRA Assets (MRY)


Total Assets

$3.68M

Total Liabilities

$800.76K

Total Investments

$0

SYRA Income (MRY)


Revenue

$7.98M

Net Income

-$3.76M

Operating Expense

$5.42M

SYRA Cash Flow (MRY)


CF Operations

-$2.93M

CF Investing

-$11.11K

CF Financing

$2.06M

SYRA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

-

0%

0%

-

2021

$0

-

-

-

-

SYRA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$3,679,332 (-25.27%)

$4,923,283 (112.24%)

$2,319,642 (332.05%)

$536,889

Assets Current

$3,352,795 (-29.87%)

$4,781,110 (235.11%)

$1,426,743 (273.35%)

$382,143

Assets Non-Current

$326,537 (129.68%)

$142,173 (-84.08%)

$892,899 (477.01%)

$154,746

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Shareholders Equity

$2,878,571 (-28.27%)

$4,013,211 (465.16%)

$710,098 (10035.61%)

-$7,147

Property Plant & Equipment Net

$326,537 (129.68%)

$142,173 (-52.09%)

$296,781 (91.79%)

$154,746

Cash & Equivalents

$2,395,405 (-26.97%)

$3,280,075 (97988.37%)

$3,344 (-96.66%)

$100,012

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0

Deferred Revenue

$16,611 (0%)

$0 (0%)

$0 (0%)

$0

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0

Trade & Non-Trade Receivables

$680,827 (-38.73%)

$1,111,248 (-7.48%)

$1,201,097 (360.85%)

$260,627

Trade & Non-Trade Payables

$101,690 (-78.04%)

$462,991 (6.29%)

$435,588 (246.45%)

$125,730

Accumulated Retained Earnings (Deficit)

-$8,824,193 (-74.22%)

-$5,064,955 (-138.17%)

-$2,126,612 (-25075.94%)

-$8,447

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0

Total Debt

$452,077 (82.21%)

$248,103 (-73.46%)

$934,839 (172.66%)

$342,864

Debt Current

$264,865 (6.76%)

$248,103 (-71.54%)

$871,640 (247.10%)

$251,120

Debt Non-Current

$187,212 (0%)

$0 (0%)

$63,199 (-31.11%)

$91,744

Total Liabilities

$800,761 (-12.01%)

$910,072 (-43.46%)

$1,609,544 (195.85%)

$544,036

Liabilities Current

$613,549 (-32.58%)

$910,072 (-41.15%)

$1,546,345 (241.89%)

$452,292

Liabilities Non-Current

$187,212 (0%)

$0 (0%)

$63,199 (-31.11%)

$91,744

SYRA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$7,982,082 (44.73%)

$5,515,144 (-1.83%)

$5,617,706 (298.43%)

$1,409,976

Cost of Revenue

$6,329,119 (54.25%)

$4,103,244 (-9.94%)

$4,555,924 (365.07%)

$979,622

Selling General & Administrative Expense

$4,163,913 (21.60%)

$3,424,217 (63.00%)

$2,100,726 (520.67%)

$338,463

Research & Development Expense

$585,146 (143.76%)

$240,048 (0%)

$0 (0%)

$0

Operating Expenses

$5,417,848 (26.01%)

$4,299,499 (36.43%)

$3,151,477 (626.76%)

$433,634

Interest Expense

$15,600 (-70.94%)

$53,686 (88.15%)

$28,533 (0%)

$0

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0

Consolidated Income

-$3,759,238 (-27.94%)

-$2,938,343 (-38.72%)

-$2,118,165 (-64478.20%)

-$3,280

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income

-$3,759,238 (-27.94%)

-$2,938,343 (-38.72%)

-$2,118,165 (-64478.20%)

-$3,280

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Income Common Stock

-$3,759,238 (-27.94%)

-$2,938,343 (-38.72%)

-$2,118,165 (-64478.20%)

-$3,280

Weighted Average Shares

$7,551,576 (54.81%)

$4,877,861 (60.40%)

$3,041,085 (264.93%)

$833,334

Weighted Average Shares Diluted

$7,551,576 (54.81%)

$4,877,861 (60.40%)

$3,041,085 (264.93%)

$833,334

Earning Before Interest & Taxes (EBIT)

-$3,743,638 (-29.78%)

-$2,884,657 (-38.05%)

-$2,089,632 (-63608.29%)

-$3,280

Gross Profit

$1,652,963 (17.07%)

$1,411,900 (32.97%)

$1,061,782 (146.72%)

$430,354

Operating Income

-$3,764,885 (-30.38%)

-$2,887,599 (-38.18%)

-$2,089,695 (-63610.21%)

-$3,280

SYRA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$11,111 (27.15%)

-$15,251 (87.42%)

-$121,260 (-1828.13%)

-$6,289

Net Cash Flow from Financing

$2,058,474 (-65.98%)

$6,051,050 (166.72%)

$2,268,657 (1084.68%)

$191,500

Net Cash Flow from Operations

-$2,932,033 (-6.27%)

-$2,759,068 (-22.95%)

-$2,244,065 (-2444.32%)

-$88,199

Net Cash Flow / Change in Cash & Cash Equivalents

-$884,670 (-127.00%)

$3,276,731 (3489.67%)

-$96,668 (-199.65%)

$97,012

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0

Capital Expenditure

-$11,111 (27.15%)

-$15,251 (87.42%)

-$121,260 (-1828.13%)

-$6,289

Issuance (Repayment) of Debt Securities

-$410,676 (-157.14%)

$718,767 (32.55%)

$542,275 (183.62%)

$191,200

Issuance (Purchase) of Equity Shares

$2,469,150 (-53.69%)

$5,332,283 (129.59%)

$2,322,500 (774066.67%)

$300

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0

Share Based Compensation

$131,181 (299.56%)

$32,831 (-93.60%)

$512,910 (0%)

$0

Depreciation Amortization & Accretion

$152,238 (212.15%)

$48,771 (-55.83%)

$110,412 (302.00%)

$27,466

SYRA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

20.70% (-19.14%)

25.60% (35.45%)

18.90% (-38.03%)

30.50%

Profit Margin

-47.10% (11.63%)

-53.30% (-41.38%)

-37.70% (-18750.00%)

-0.20%

EBITDA Margin

-45.00% (12.45%)

-51.40% (-46.02%)

-35.20% (-2170.59%)

1.70%

Return on Average Equity (ROAE)

-128.00% (80.03%)

-641.00% (-6.37%)

-602.60%

-

Return on Average Assets (ROAA)

-94.60% (6.43%)

-101.10% (31.83%)

-148.30%

-

Return on Sales (ROS)

-46.90% (10.33%)

-52.30% (-40.59%)

-37.20% (-18500.00%)

-0.20%

Return on Invested Capital (ROIC)

-366.30% (-166.79%)

-137.30% (33.22%)

-205.60%

-

Dividend Yield

0% (0%)

0%

-

-

Price to Earnings Ratio (P/E)

-0.82 (51.33%)

-1.69

-

-

Price to Sales Ratio (P/S)

0.39 (-56.57%)

0.9

-

-

Price to Book Ratio (P/B)

1.28 (-63.55%)

3.52

-

-

Debt to Equity Ratio (D/E)

0.28 (22.47%)

0.23 (-89.99%)

2.27 (102.98%)

-76.12

Earnings Per Share (EPS)

-0.5 (16.67%)

-0.6 (14.29%)

-0.7 (0%)

0

Sales Per Share (SPS)

1.06 (-6.54%)

1.13 (-38.77%)

1.85 (9.16%)

1.69

Free Cash Flow Per Share (FCFPS)

-0.39 (31.46%)

-0.57 (26.86%)

-0.78 (-588.50%)

-0.11

Book Value Per Share (BVPS)

0.38 (-53.71%)

0.82 (251.71%)

0.23 (2700.00%)

-0.01

Tangible Assets Book Value Per Share (TABVPS)

0.49 (-51.73%)

1.01 (32.24%)

0.76 (18.48%)

0.64

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-6

-

-

Enterprise Value Over EBITDA (EV/EBITDA)

-0.44 (92.55%)

-5.85

-

-

Asset Turnover

2.01 (5.90%)

1.9 (-51.77%)

3.93

-

Current Ratio

5.46 (4.02%)

5.25 (469.23%)

0.92 (9.23%)

0.84

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0

Free Cash Flow (FCF)

-$2,943,144 (-6.09%)

-$2,774,319 (-17.29%)

-$2,365,325 (-2403.31%)

-$94,488

Enterprise Value (EV)

$1,564,551 (-90.57%)

$16,587,877

-

-

Earnings Before Tax (EBT)

-$3,759,238 (-27.94%)

-$2,938,343 (-38.72%)

-$2,118,165 (-64478.20%)

-$3,280

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$3,591,400 (-26.64%)

-$2,835,886 (-43.28%)

-$1,979,220 (-8283.33%)

$24,186

Invested Capital

$1,122,455 (14.39%)

$981,239 (-42.44%)

$1,704,792 (420.63%)

$327,449

Working Capital

$2,739,246 (-29.24%)

$3,871,038 (3336.60%)

-$119,602 (-70.50%)

-$70,149

Tangible Asset Value

$3,679,332 (-25.27%)

$4,923,283 (112.24%)

$2,319,642 (332.05%)

$536,889

Market Capitalization

$3,696,298 (-73.86%)

$14,140,208

-

-

Average Equity

$2,937,700 (540.90%)

$458,370 (30.41%)

$351,476

-

Average Assets

$3,973,526 (36.68%)

$2,907,270 (103.55%)

$1,428,266

-

Invested Capital Average

$1,022,072 (-51.34%)

$2,100,293 (106.70%)

$1,016,120

-

Shares

8,973,774 (-35.54%)

13,921,638 (40.85%)

9,883,697

-